ℹ️
🇨🇿
Hledání
Hledat osoby relevantní k dotazu "stanoviska"
stanoviska
Osoba
Předměty
Osoby
Publikace
Studium
PharmDr. Eliška Potůčková Ph.D.
Externí osoba na Farmaceutická fakulta v Hradci Králové
27 publikací
Publikace
publication
Restored biosynthetic pathways induced by MSCs serve as rescue mechanism in leukemia cells after L-asparaginase therapy
2023 |
2. lékařská fakulta, Přírodovědecká fakulta
publication
Chimeric JAK2 Kinases Trigger Non-uniform Changes of Cellular Metabolism in BCR-ABL1-like Childhood ALL
2023 |
Ústřední knihovna, 2. lékařská fakulta
publication
Frequency and prognostic impact of ZEB2 H1038 and 1072 mutations in childhood B-other acute lymphoblastic leukemia
2021 |
2. lékařská fakulta
publication
Chromosome 21 gain is dispensable for transient myeloproliferative disorder driven by a novel GATA1 mutation
2020 |
2. lékařská fakulta
publication
ERG deletions in childhood acute lymphoblastic leukemia with DUX4 rearrangements are mostly polyclonal, prognostically relevant and their detection rate strongly depends on screening method sensitivity
2019 |
2. lékařská fakulta
publication
Two novel fusion genes, AIF1L-ETV6 and ABL1-AIF1L, result together with ETV6-ABL1 from a single chromosomal rearrangement in acute lymphoblastic leukemia with prenatal origin
2018 |
2. lékařská fakulta, 3. lékařská fakulta
publication
Structure-Activity Relationships of Nitro-Substituted Aroylhydrazone Iron Chelators with Antioxidant and Antiproliferative Activities
2018 |
Farmaceutická fakulta v Hradci Králové
publication
Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology
2017 |
2. lékařská fakulta
publication
Intragenic ERG Deletions Do Not Explain the Biology of ERG-Related Acute Lymphoblastic Leukemia
2016 |
2. lékařská fakulta
publication
Aroylhydrazone iron chelators: Tuning antioxidant and antiproliferative properties by hydrazide modifications
2016 |
Farmaceutická fakulta v Hradci Králové
Načíst další publikace (17)
Loading network view...